Cytek Biosciences, Inc. announced that Patrik Jeanmonod has been appointed as the company?s head of corporate development analytics. Jeanmonod served as Cytek?s chief financial officer since 2018.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.84 USD | -2.18% | -4.94% | -35.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.58% | 784M | |
+10.27% | 226B | |
+14.12% | 198B | |
+18.21% | 142B | |
+29.25% | 111B | |
+2.09% | 65.26B | |
+14.55% | 54.36B | |
+6.68% | 50.94B | |
+8.46% | 44.8B | |
+3.00% | 36.8B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences, Inc. Announces Appointment of Patrik Jeanmonod as Head of Corporate Development Analytics